3SBio Investor Relations Material
Latest events
H2 2024
25 Mar, 2025
H1 2024
21 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from 3SBio Inc
Access all reports
3SBio Inc. is a China-based biotechnology company engaged in the research, development, manufacturing, and commercialization of biopharmaceutical products. The company focuses on therapeutic areas such as oncology, nephrology, autoimmune diseases, and dermatology. Its product portfolio includes monoclonal antibodies, recombinant proteins, and other biologic treatments. The company is headquartered in Shenyang, China, and its shares are listed on the HKEX.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
1530
Country
🇭🇰 Hong Kong